You are here: Industry Insights > Chief Executive Officer

News List

IMG Appoints Steve Paraboschi as Chief Executive Officer prnasia
August 10, 2021
International Medical Group® (IMG®), an industry-leading international medical insurance, global assistance, and travel insurance company, is pleased to announce that Steve Paraboschi has been appointed as Chief Executive Officer, effective immediately.
Himalaya Therapeutics Announces Appointment of Brian Zhang as Chief Executive Officer prnasia
April 28, 2021
Himalaya Therapeutics, a clinical-stage biopharmaceutical company focused on development and commercialization in Greater China of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, which are based on the ...
Apotex Names New Presdient, Chief Executive Officer americanpharmaceuticalreview
December 21, 2020
Apotex has announced its board of directors has appointed Peter Hardwick as President & Chief Executive Officer of Apotex Corp., effective immediately.
A2A Pharmaceuticals Appoints Dr. Sotirios Stergiopoulos Chief Executive Officer prnasia
July 05, 2019
A2A Pharmaceuticals Inc. (A2A), a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents ...
IntelGenx to Promote Oral Films CDMO Services at CPhI North America contractpharma
April 24, 2019
Oral drug delivery company IntelGenx will promote its contract development and manufacturing organization (CDMO) services capabilities using its existing proprietary VersaFilm...
Ajinomoto Appoints VP of Sales & Marketing pharmatimes
April 04, 2019
Ajinomoto Bio-Pharma Services, a global provider of bio-pharmaceutical contract development and manufacturing services, has appointed Jean-Baptiste Agnus as vice president of sales and marketing.
CytoDyn, Samsung BioLogics Enter Mfg. Agreement contractpharma
April 03, 2019
Will make $1 billion worth of Leronlimab to meet expected demand for future revenues post-approval
Dr. Gustavo Mahler Resigns as Chief Executive Officer of AGC Biologics, Patricio Massera to Succeed as CEO Effective May 1st, 2019 en-cphi.cn
April 03, 2019
AGC Biologics today announces a change in executive leadership. Dr. Gustavo Mahler has decided to leave his position as CEO effective April 30th, 2019 after a 10 year tenure with CMC Biologics and AGC Biologics.
Paratek Pharma Management Change contractpharma
March 19, 2019
Douglas Pagán resigns as CFO, Sarah Higgins to assume responsibilities on interim basis.
Cellectis to Build Mfg. Facility in North Carolina contractpharma
March 13, 2019
With help from CMO partners, advances further towards commercialization of UCART portfolio

Previous page 1 2 3 4 Next page